Sotera Health Analyst Price Targets - Benzinga

Sotera Health Co

SHCNASDAQ

Trade with Public

Trade with Public

$17.64

-0.25-1.4%

最終更新: Oct 19, 4:11 PM

$17.70

-0.19-1.07%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

© 2026 Benzinga | All Rights Reserved

Sotera Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Sotera Health (SHC).

Price Target Range — 12 Quarters

Analyst Consensus — 9 Analysts

8Buy

1Sell

Consensus RatingBuy# Analysts9Avg. Consensus PT$21Upside to Avg. PT+17.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 14, 2026	JP Morgan	Casey Woodring	Downgrade	Neutral→Underweight	$17
Aug 7, 2026	Citigroup	Brendan Digan	PT Raise	Buy	$23→$25
Aug 7, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$19→$22
Aug 7, 2026	Piper Sandler	Jason Bednar	PT Raise	Overweight	$22→$25
Aug 7, 2026	JP Morgan	Casey Woodring	PT Raise	Neutral	$16→$18
Jun 24, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$18→$19
Jun 5, 2026	Goldman Sachs	Evie Koslosky	Initiate	Buy	$20
May 6, 2026	Piper Sandler	Jason Bednar	PT Cut	Overweight	$24→$22
Apr 14, 2026	Barclays	Luke Sergott	PT Cut	Overweight	$20→$18
Feb 24, 2026	Citigroup	Patrick Donnelly	PT Raise	Buy	$21→$23
Jan 9, 2026	RBC Capital	Sean Dodge	Reinstates	Outperform	$24
Jan 9, 2026	Piper Sandler	Jason Bednar	Upgrade	Neutral→Overweight	$17→$24
Dec 18, 2025	William Blair	Max Smock	Initiate	Outperform	—
Nov 13, 2025	BMO Capital	Sean Dodge	Initiate	Outperform	$19
Nov 5, 2025	JP Morgan	Casey Woodring	PT Raise	Neutral	$14→$16
Nov 5, 2025	Barclays	Luke Sergott	PT Raise	Overweight	$19→$20
Nov 5, 2025	Piper Sandler	Jason Bednar	PT Raise	Neutral	$15→$17
Oct 2, 2025	Barclays	Luke Sergott	PT Raise	Overweight	$17→$19
Jun 24, 2025	Barclays	Luke Sergott	PT Cut	Overweight	$15→$13
May 5, 2025	Goldman Sachs	Matthew Sykes	Upgrade	Neutral→Buy	$14→$17

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Downgrades Sotera Health to Underweight, Announces $17 Price Target

JP Morgan analyst Casey Woodring downgrades Sotera Health (NASDAQ:SHC) from Neutral to Underweight and announces $17 price target.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Sotera Health, Raises Price Target to $25

Citigroup analyst Brendan Digan maintains Sotera Health (NASDAQ:SHC) with a Buy and raises the price target from $23 to $25.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $22

Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $19 to $22.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on Sotera Health, Raises Price Target to $25

Piper Sandler analyst Jason Bednar reiterates Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $22 to $25.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Sotera Health, Raises Price Target to $18

JP Morgan analyst Casey Woodring maintains Sotera Health (NASDAQ:SHC) with a Neutral and raises the price target from $16 to $18.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $19

Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $18 to $19.

Benzinga Newsdesk